Skip to main content
Premium Trial:

Request an Annual Quote

Bionomics and Australian Institute Sign Epilepsy Gene, CNS Research Pact

NEW YORK, Feb. 25 - Australian genomics-based drug discovery firm Bionomics has established a research collaboration in the area of epilepsy and CNS disorders with the Howard Florey Research Insititute in Melbourne, the company said today.


Bionomics, based in Adelaide, Australia, focuses on discovering and characterizing disease-related genes, especially in breast cancer, epilepsy, and angiogenesis.


The Howard Florey Institute, headed up by professor Frederick Mendelsohn, focuses its research on brain and peripheral nervous system areas, including neurochemistry, neurobiology, and neuroinformatics.



The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.